Corporates Ginkgo Bioworks and Bayer have launched a plant microbiome technology startup that is equipped with $100m in series A funding.
Chemical and life sciences technology producer Bayer and microbe engineering company Ginkgo Bioworks have combined to launch a US-based plant microbiome technology startup with $100m of series A funding.
The capital was provided by Ginkgo, Bayer subsidiary Bayer LifeScience Centre and hedge fund Viking Global Investors.
The startup will research novel approaches to using plant-based microbes, with an initial focus on yielding nitrogen from the bacteria to satisfy deficiencies within many crops. Farmers often use ammonia-based nitrogen fertilisers at present…
